Hikma Pharmaceuticals PLC (LSE:HIK)
£ 18.67 -0.12 (-0.64%) Market Cap: 4.13 Bil Enterprise Value: 4.85 Bil PE Ratio: 27.27 PB Ratio: 2.33 GF Score: 90/100

Half Year 2021 Hikma Pharmaceuticals PLC Earnings Presentation - Pre-Recorded Transcript

Aug 06, 2021 / 07:00AM GMT
Release Date Price: £24.55 (-7.08%)
Sigurdur Oli Olafsson
Hikma Pharmaceuticals PLC - CEO & Executive Director

Presentation - Pre-Recorded
Aug 06, 2021 / 07:00AM GMT

=====================
Corporate Participants
=====================
* Khalid Waleed Hosny Al Nabilsi
Hikma Pharmaceuticals PLC - CFO
* Sigurdur Oli Olafsson
Hikma Pharmaceuticals PLC - CEO & Executive Director

=====================
-

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot